What is the appropriate ICD‑10 code for enlarged red blood cells (macrocytosis) while awaiting vitamin B12, folate, and thyroid‑stimulating hormone (TSH) test results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Macrocytosis (Enlarged RBCs)

Use ICD-10 code D75.89 (Other specified diseases of blood and blood-forming organs) for macrocytosis when awaiting B12, folate, and TSH results.

Primary Coding Recommendation

The most appropriate code for enlarged red blood cells (macrocytosis) in the workup phase is D75.89, which covers "other specified diseases of blood and blood-forming organs." This is the standard code used when you've identified macrocytosis on CBC but haven't yet determined the underlying cause.

Alternative Coding Options

Depending on your documentation and clinical context, you may also consider:

  • R71.8 (Other abnormality of red blood cells) - if you're emphasizing the abnormal lab finding itself
  • D53.9 (Nutritional anemia, unspecified) - if anemia is present and you suspect nutritional deficiency but are awaiting confirmation

Clinical Context from Guidelines

The workup you're ordering is appropriate and evidence-based. Recent NICE guidelines 1 emphasize that macrocytosis is a key sign of vitamin B12 deficiency, and your testing strategy (B12, folate, TSH) aligns with standard diagnostic algorithms 2. The most common causes of macrocytosis are vitamin B12 deficiency, folate deficiency, hypothyroidism, alcoholism, and liver disease 3, 2.

Important Coding Considerations

  • Don't code the suspected diagnosis yet - avoid using codes like E53.8 (B12 deficiency) or E03.9 (hypothyroidism) until lab results confirm the diagnosis
  • Document the MCV value in your note (macrocytosis is typically defined as MCV >100 fL)
  • Update the diagnosis code once you receive lab results to reflect the specific etiology (e.g., D51.0 for pernicious anemia, E03.9 for hypothyroidism, D52.9 for folate deficiency)

Common Pitfall to Avoid

Many clinicians under-recognize or fail to evaluate macrocytosis, particularly when the MCV is only mildly elevated (100-105 fL) 4. However, even mild macrocytosis can indicate clinically significant and treatable disease, including B12 deficiency and hypothyroidism 4. Your proactive workup is appropriate regardless of the degree of MCV elevation.

Related Questions

What is the initial evaluation and management of a patient with macrocytosis?
What is the appropriate management for a patient with macrocytic anemia and low MCHC?
How to manage a patient with lymphopenia and potential macrocytic anemia?
What is the evaluation and treatment approach for a patient with a high reticulocyte (reticulocyte count) count and macrocytosis (large red blood cells)?
In a patient with macrocytosis (MCV 105 fL), low MCHC, normal vitamin B12, modest absolute monocytosis, neutrophilia (69%), lymphopenia (16%), elevated monocyte percentage (12.5%), and normal anion gap, what is the most likely etiology and what initial diagnostic tests and management steps should be taken?
Is there a natural way to lower norepinephrine levels?
In a patient with third-degree (complete) heart block and a ventricular rate in the 20s, what is the role of atropine, its dosing, and the recommended next steps if the rate does not improve?
What is the appropriate acetaminophen (Tylenol) suppository dose for a 1.5-year-old toddler weighing 24 lb (≈11 kg) with fever?
Is castor oil safe for patients with chronic kidney disease or on dialysis?
In a patient with head trauma, what is the significance of elevated erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) and what management steps are recommended?
What are the recommended starting doses and titration schedules for carvedilol in adults with chronic heart failure and hypertension, and how should dosing be adjusted in elderly patients and those with moderate hepatic impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.